There is now a way to prevent type 1 diabetes and push it back by several years
Endocrine and Psychiatry Center
Dear EPC Patients and Family Members,
The early screening and detection of Type 1 Diabetes is very important for prevention and management of the condition. In fact, there is a 15x increased risk of developing T1D if there is a family history. Based on your patient’s family history, we recommend Type 1 Diabetes Autoantibody screening to help with possible earlier detection of the condition. Teplizumab is the first FDA approved drug that can delay the onset of Type 1 Diabetes and can be initiated early in the disease process.
Below are the labs and codes for ordering Type 1 Diabetes Autoantibodies at any local lab.
If your patient's autoantibodies are positive then please call our office (832-593-8100) so we can get them scheduled as soon as possible.
Type |
Code |
Description |
CPT (Immunoassays for T1D Related Autoantibodies) |
CPT Code 86341 |
Glutamic acid decarboxylase autoantibodies (GADA) |
Islet Tyrosine phosphatase autoantibodies (IA-2A) |
||
Zinc transporter 8 autoantibodies (ZnT8A) |
||
CPT code 86337 Test Code 36178 |
Insulin autoantibodies (IAA) |
|
ICD-10-CM (Screening and Diagnosis) |
E10.1 - E10.9 |
Diagnosis for Type 1 Diabetes |
Z13.1 |
Encounter for screening for diabetes mellitus |
|
Z13.9 |
Encounter for screening, unspecified |
|
Z83.3 |
Family history of diabetes mellitus |
|
Z83.49 |
Family history of other endocrine, nutritional and metabolic disease |
|
E34.9 |
Endocrine disorder, unspecified |
If you have any questions or concerns, please feel free to contact our office to get scheduled.
Regards,
Rakesh Patel, DO